MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1124/jpet.117.243717

Медицинская библиотека · The Journal of pharmacology and experimental therapeutics · 2017

Discovery of Novel Small-Molecule Inducers of Heme Oxygenase-1 That Protect Human iPSC-Derived Cardiomyocytes from Oxidative Stress.

Kirby R Jason, Divlianska Daniela B, Whig Kanupriya, Bryan Nadezda, Morfa Camilo J, Koo Ada, Nguyen Kevin H, Maloney Patrick, Peddibhotla Satayamaheshwar, Sessions E Hampton, Hershberger Paul M, Smith Layton H, Malany Siobhan

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Oxidative injury to cardiomyocytes plays a critical role in cardiac pathogenesis following myocardial infarction. Transplantation of stem cell-derived cardiomyocytes has recently progressed as a novel treatment to repair damaged cardiac tissue but its efficacy has been limited by poor survival of transplanted cells owing to oxidative stress in the post-transplantation environment. Identification of small molecules that activate cardioprotective pathways to prevent oxidative damage and increase survival of stem cells post-transplantation is therefore of great interest for improving the efficacy of stem cell therapies. This report describes a chemical biology phenotypic screening approach to identify and validate small molecules that protect human-induced pluripotent stem cell cardiomyocytes (hiPSC-CMs) from oxidative stress. A luminescence-based high-throughput assay for cell viability was used to screen a diverse collection of 48,640 small molecules for protection of hiPSC-CMs from peroxide-induced cell death. Cardioprotective activity of "hit" compounds was confirmed using impedance-based detection of cardiomyocyte monolayer integrity and contractile function. Structure-activity relationship studies led to the identification of a potent class of compounds with 4-(pyridine-2-yl)thiazole scaffold. Examination of gene expression in hiPSC-CMs revealed that the hit compound, designated cardioprotectant 312 (CP-312), induces robust upregulation of heme oxygenase-1, a marker of the antioxidant response network that has been strongly correlated with protection of cardiomyocytes from oxidative stress. CP-312 therefore represents a novel chemical scaffold identified by phenotypic high-throughput screening using hiPSC-CMs that activates the antioxidant defense response and may lead to improved pharmacological cardioprotective therapies.

Для цитирования: Kirby R Jason, Divlianska Daniela B, Whig Kanupriya, Bryan Nadezda, Morfa Camilo J, Koo Ada, Nguyen Kevin H, Maloney Patrick, Peddibhotla Satayamaheshwar, Sessions E Hampton, Hershberger Paul M, Smith Layton H, Malany Siobhan. Discovery of Novel Small-Molecule Inducers of Heme Oxygenase-1 That Protect Human iPSC-Derived Cardiomyocytes from Oxidative Stress.. The Journal of pharmacology and experimental therapeutics. 2017. DOI: 10.1124/jpet.117.243717.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.